FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116543013> ?p ?o ?g. }

• W2116543013 endingPage "812" @default.
• W2116543013 startingPage "803" @default.
• W2116543013 abstract "Purpose: To retrospectively assess whether magnetic resonance (MR) imaging and MR spectroscopic imaging and selected molecular markers correlate with each other and with clinically insignificant and significant prostate cancer (PCa), as defined at surgical pathologic analysis. Materials and Methods: The institutional review board approved this HIPAA-compliant study and waived informed consent. Eighty-nine men (mean age, 63 years; range, 46–79 years) with biopsy-proved PCa underwent combined endorectal MR imaging and MR spectroscopic imaging before radical prostatectomy. Suspicion of clinically insignificant PCa was retrospectively and separately recorded for MR imaging and combined MR imaging and MR spectroscopic imaging by using a scale of 0–3. Clinically insignificant PCa was pathologically defined as organ-confined cancer of 0.5 cm3 or less without poorly differentiated elements. Prostatectomy specimens underwent immunohistochemical analysis for three molecular markers: Ki-67, phospho-Akt (pAkt), and androgen receptor (AR). To examine differences in marker levels for clinically insignificant and significant cancer, a Wilcoxon rank sum test was used. To examine correlations between marker levels and MR imaging or combined MR imaging and MR spectroscopic imaging scores, the Spearman correlation was used. Results: Twenty-one (24%) patients had clinically insignificant and 68 (76%) had clinically significant PCa at surgical pathologic review. All markers were significantly correlated with MR imaging and combined MR imaging and MR spectroscopic imaging findings (all correlation coefficients >0.5). In differentiating clinically insignificant from clinically significant PCa, areas under the receiver operating characteristic curves for Ki-67, AR, pAkt, MR imaging, and combined MR imaging and MR spectroscopic imaging were 0.75, 0.78, 0.80, 0.85, and 0.91, respectively. Conclusion: The use of pretreatment MR imaging or combined MR imaging and MR spectroscopic imaging and molecular marker analyses of biopsy samples could facilitate better treatment selection. Supplemental material: http://radiology.rsnajnls.org/cgi/content/full/250/3/803/DC1 © RSNA, 2009" @default.
• W2116543013 created "2016-06-24" @default.
• W2116543013 creator A5010536553 @default.
• W2116543013 creator A5012224683 @default.
• W2116543013 creator A5021013894 @default.
• W2116543013 creator A5040809833 @default.
• W2116543013 creator A5045599324 @default.
• W2116543013 creator A5053926080 @default.
• W2116543013 creator A5059124819 @default.
• W2116543013 creator A5078241882 @default.
• W2116543013 creator A5080940311 @default.
• W2116543013 date "2009-03-01" @default.
• W2116543013 modified "2023-10-18" @default.
• W2116543013 title "Correlation of MR Imaging and MR Spectroscopic Imaging Findings with Ki-67, Phospho-Akt, and Androgen Receptor Expression in Prostate Cancer" @default.
• W2116543013 cites W1964704628 @default.
• W2116543013 cites W1971765692 @default.
• W2116543013 cites W1984829389 @default.
• W2116543013 cites W1986096001 @default.
• W2116543013 cites W1990422347 @default.
• W2116543013 cites W1991964551 @default.
• W2116543013 cites W2000351498 @default.
• W2116543013 cites W2006768292 @default.
• W2116543013 cites W2008875502 @default.
• W2116543013 cites W2012531224 @default.
• W2116543013 cites W2019158536 @default.
• W2116543013 cites W2019789647 @default.
• W2116543013 cites W2029481468 @default.
• W2116543013 cites W2032341434 @default.
• W2116543013 cites W2035809577 @default.
• W2116543013 cites W2048440423 @default.
• W2116543013 cites W2055338605 @default.
• W2116543013 cites W2056164819 @default.
• W2116543013 cites W2059968629 @default.
• W2116543013 cites W2065825082 @default.
• W2116543013 cites W2070077932 @default.
• W2116543013 cites W2077591651 @default.
• W2116543013 cites W2082681241 @default.
• W2116543013 cites W2088052532 @default.
• W2116543013 cites W2088285013 @default.
• W2116543013 cites W2100942607 @default.
• W2116543013 cites W2102577568 @default.
• W2116543013 cites W2108638403 @default.
• W2116543013 cites W2109269939 @default.
• W2116543013 cites W2111791000 @default.
• W2116543013 cites W2117996979 @default.
• W2116543013 cites W2118436380 @default.
• W2116543013 cites W2118625479 @default.
• W2116543013 cites W2119973007 @default.
• W2116543013 cites W2121447320 @default.
• W2116543013 cites W2126061829 @default.
• W2116543013 cites W2126776304 @default.
• W2116543013 cites W2140187019 @default.
• W2116543013 cites W2145491305 @default.
• W2116543013 cites W2145835967 @default.
• W2116543013 cites W2150292610 @default.
• W2116543013 cites W2154787687 @default.
• W2116543013 cites W2160757395 @default.
• W2116543013 cites W2161025941 @default.
• W2116543013 cites W2163195821 @default.
• W2116543013 cites W2163239105 @default.
• W2116543013 cites W2163791962 @default.
• W2116543013 cites W2292896901 @default.
• W2116543013 cites W2328176404 @default.
• W2116543013 cites W4252605154 @default.
• W2116543013 doi "https://doi.org/10.1148/radiol.2503080473" @default.
• W2116543013 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2680166" @default.
• W2116543013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19244047" @default.
• W2116543013 hasPublicationYear "2009" @default.
• W2116543013 type Work @default.
• W2116543013 sameAs 2116543013 @default.
• W2116543013 citedByCount "30" @default.
• W2116543013 countsByYear W21165430132012 @default.
• W2116543013 countsByYear W21165430132013 @default.
• W2116543013 countsByYear W21165430132014 @default.
• W2116543013 countsByYear W21165430132015 @default.
• W2116543013 countsByYear W21165430132016 @default.
• W2116543013 countsByYear W21165430132019 @default.
• W2116543013 countsByYear W21165430132021 @default.
• W2116543013 countsByYear W21165430132022 @default.
• W2116543013 crossrefType "journal-article" @default.
• W2116543013 hasAuthorship W2116543013A5010536553 @default.
• W2116543013 hasAuthorship W2116543013A5012224683 @default.
• W2116543013 hasAuthorship W2116543013A5021013894 @default.
• W2116543013 hasAuthorship W2116543013A5040809833 @default.
• W2116543013 hasAuthorship W2116543013A5045599324 @default.
• W2116543013 hasAuthorship W2116543013A5053926080 @default.
• W2116543013 hasAuthorship W2116543013A5059124819 @default.
• W2116543013 hasAuthorship W2116543013A5078241882 @default.
• W2116543013 hasAuthorship W2116543013A5080940311 @default.
• W2116543013 hasBestOaLocation W21165430132 @default.
• W2116543013 hasConcept C121608353 @default.
• W2116543013 hasConcept C126322002 @default.
• W2116543013 hasConcept C126838900 @default.
• W2116543013 hasConcept C141071460 @default.
• W2116543013 hasConcept C142724271 @default.
• W2116543013 hasConcept C143409427 @default.
• W2116543013 hasConcept C2775934546 @default.
• W2116543013 hasConcept C2776235491 @default.

• next